International chemistry sales jumped more than 450% from one quarter to the next at Flotek
Flotek (FTK) raised its 2026 revenue guidance to $360M–$370M and Adjusted EBITDA to $50M–$54M, citing strong international chemistry sales. Q2 2026 international chemistry revenue surged over 450% sequentially to $10.6M, with 2H 2026 sales potentially exceeding $40M. The stock gained 10.92% on the news.
How this was made
The 30-second read
Why it matters
The guidance lift and 450% segment sales surge provide fresh, material information that can drive short‑term price moves.
Market read
The new guidance and rapid segment growth have already moved the stock up ~11%, making the story highly relevant for traders.
What to watch
Excludes $9 M of non‑cash contract‑asset amortization, which could reduce adjusted EBITDA if added back.
Background
Flotek Industries, a NYSE‑listed provider of chemistry and data technology for the energy industry, issued an updated 2026 guidance after a strong Q2 performance.
Ticker impact
Flotek raised its 2026 revenue and Adjusted EBITDA guidance, reporting a 450% sequential jump in international chemistry sales and prompting a 10.9% share price gain.
Expect continued buying pressure; price could test the next resistance around $30‑$31.
The guidance increase is material, the segment growth is dramatic, and the stock already rallied 10% on the news.
Market effects
The strong international chemistry sales may lift peers in the specialty chemicals and data‑technology space.
Positive for energy‑related service providers operating in international markets.
Highlights demand for real‑time data and chemistry solutions across the energy sector worldwide.
Counterpoint
The guidance assumes sustained demand; a slowdown in energy markets could pressure the outlook.
Key entities
- companyFlotek Industries, Inc.
NYSE‑listed provider of chemistry and data solutions for the energy sector.
- executiveDr. Ryan Ezell
Chief Executive Officer of Flotek, quoted on the guidance increase.
